NCT02410590 Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104) Status WITHDRAWN Phase PHASE4
NCT02408159 Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy Status TERMINATED Phase PHASE4
NCT02407600 Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy Status UNKNOWN Phase PHASE2
NCT02406781 Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial Status COMPLETED Phase PHASE2
NCT02406443 The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion Status COMPLETED Phase PHASE4
NCT02403674 Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021) Status COMPLETED Phase PHASE3
NCT02397096 Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024) Status COMPLETED Phase PHASE3
NCT02395627 Reversing Therapy Resistance With Epigenetic-Immune Modification Status TERMINATED Phase PHASE2
NCT02394730 Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints Status COMPLETED Phase PHASE1/PHASE2
NCT02394600 The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation Status COMPLETED Phase PHASE4
NCT02392494 Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002) Status COMPLETED Phase PHASE1
NCT02387983 Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117) Status COMPLETED Phase PHASE1
NCT02383355 Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation Status COMPLETED Phase PHASE4
NCT02383290 The Implementation of Pharmacogenomics Into Primary Care in British Columbia Status COMPLETED Phase NA
NCT02382900 Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City Status UNKNOWN Phase PHASE3
NCT02382406 Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC Status TERMINATED Phase PHASE1/PHASE2
NCT02379858 Gastrointestinal Tract Recovery in Patients Undergoing Open Ventral Hernia Repair Status TERMINATED Phase NA
NCT02375672 Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02370498 A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061) Status COMPLETED Phase PHASE3